David Friedman, M.D.
MANAGING DIRECTOR AND SENIOR ANALYST, Suvretta Capital Management
Dr. Friedman is currently a Managing Director and Senior Analyst at Suvretta Capital Management, LLC for its healthcare/biotech-focused Averill investment strategies. Previously, Dr. Friedman was a Healthcare Analyst at Scopia Capital Management, and before that worked in biotechnology equity research at Morgan Stanley.
Dr. Friedman attended schools including Duke University, the University of Pittsburgh School of Medicine, and Harvard Business School.